2024-05-15T17:28:56-05:00 2023-06-30 231980475 KREISCHER MILLER 100 WITMER ROAD SUITE 350 HORSHAM PA 190442369 990 2022-07-01 237089361 CLINICAL AND LABORATORY STANDARDS INSTITUTE CLIN 6106880100 1055 WESTLAKES DRIVE 300 BERWYN PA 19312 CECILIA PORTO VP, FINANCE AND ACCOUNTING 6106880100 2024-04-29 1 CECILIA PORTO XXX-XX-XXXX 1 CHRISTOPHER M PEKULA P00734965 2154414600 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z CECILIA PORTO 1055 WESTLAKES DRIVE 300 BERWYN PA 19312 11932693 0 X WWW.CLSI.ORG X 1969 PA DEVELOP CLINICAL AND LABORATORY PRACTICES AND PROMOTE THEIR USE WORLDWIDE. 16 16 38 2000 0 0 4357350 2531195 3827358 4299669 504761 295573 2958767 2840088 11648236 9966525 0 0 0 0 5118276 4828306 0 0 0 4695528 4003353 9813804 8831659 1834432 1134866 16582235 19023956 3250627 3641782 13331608 15382174 X SEE SCHEDULE O 0 0 5451101 5796219 SEE SCHEDULE O 5451101 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 23 0 1 38 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 PA FL X X BARBARA JONES CEO 6106880100 1055 WESTLAKES DRIVE SUITE 300 BERWYN PA 19312 RANDALL T HAYDEN BOARD MEMBER 1.00 X 0 0 0 BARBARA L ZIMMER BOARD MEMBER 1.00 X 0 0 0 COLLETTE FITZGERALD BOARD MEMBER 1.00 X 0 0 0 GARY PROCOP SECRETARY 1.00 X 0 0 0 JOSEPH PASSARELLI TREASURER 1.00 X X 0 0 0 JAMES NICHOLS PRESIDENT ELECT 1.00 X X 0 0 0 CARL MOTTRAM IMMEDIATE PAST PRESIDENT 1.00 X X 0 0 0 LEONTHENA CARRINGTON BOARD MEMBER 1.00 X 0 0 0 LORALIE J LANGMAN BOARD MEMBER 1.00 X 0 0 0 LORIN BACHMANN BOARD MEMBER 1.00 X X 0 0 0 PAULA VAGNONE BOARD MEMBER 1.00 X 0 0 0 TANIA MOTSCHMAN BOARD MEMBER 1.00 X 0 0 0 ANDREW QUINTEZ BOARD MEMBER 1.00 X 0 0 0 SUSAN SHARP BOARD MEMBER 1.00 X 0 0 0 VICTOR WADDELL PRESIDENT 1.00 X X 0 0 0 BARBARA J JONES CEO AND BOARD MEMBER 40.00 X X 237221 0 12476 GLEN FINE FORMER CEO AND BOARD MEMBE 40.00 X X 365906 0 20346 PATRICK MCGINN FORMER VP MARKETING & MEMBERSHIP 40.00 X 228762 0 17858 JENNIFER ADAMS VP STANDARDS & QUALITY 40.00 X 221229 0 21614 CECILIA PORTO VP, FINANCE AND ACCOUNTING 40.00 X 186239 0 23113 PATRICK MATETA VP GLOBAL HEALTH PARTNERSH 40.00 X 216551 0 31800 MELISSA MEEKS DIRECTOR, EDUCATION AND DEVELOPMENT 40.00 X 135223 0 7341 CATHERINE BARNETT DIRECTOR, MEMBERSHIP 40.00 X 132714 0 11795 TABHITA KERN DIRECTOR, STANDARDS DEVELOPMENT 40.00 X 105301 0 19768 DAVID STERRY DIRECTOR, STANDARDS DEVELO 40.00 X 126644 0 26156 KATHARINE CASTAGNA DIRECTOR, STANDARDS DEVELO 40.00 X 111932 0 26205 2067722 0 218472 14 0 1 0 0 25000 2506195 2531195 MEMBERSHIP DUES 541900 3979364 3979364 GLOBAL HEALTH PROGRAM INCOME 541900 282999 282999 EDUCATIONAL PROGRAM INCOME 541900 37306 37306 4299669 318042 318042 1343538 1343538 1799105 1821574 -22469 -22469 -22469 1641144 144594 1496550 1496550 9966525 5796219 0 1639111 X 1227363 1227363 2860516 2234151 626365 113409 53302 60107 346465 236807 109658 280553 131860 148693 9742 9742 33485 33485 1063519 921584 141935 314310 314310 444719 288793 155926 485480 272402 213078 96062 49345 46717 1400684 1178315 222369 46965 29367 17598 41545 25978 15567 DUES AND SUBSCRIPTIONS 39340 1314 38026 EDUCATION PROGRAM EXPEN 27883 27883 BAD DEBT RECOVERY -381 -381 8831659 5451101 3380558 0 23 23 1921309 3350766 545964 135455 447918 307187 21359 36217 268265 331213 3322 3322 0 0 13255175 14763838 90872 75257 31350 24000 16582235 19023956 1007309 1000144 2243318 2641638 3250627 3641782 X 13331608 15382174 13331608 15382174 16582235 19023956 1134866 915699 0 X X 0 1 X 1 1 1 X 2594466 1220704 2235915 4357350 2531195 12939630 5792273 5795732 6228325 6673452 5940813 30430595 8386739 7016436 8464240 11030802 8472008 43370225 0 0 0 43370225 284645 385016 397667 499620 1661580 3228528 284645 385016 397667 499620 1661580 3228528 522606 170000 206863 899469 9193990 7571452 9068770 11530422 10133588 47498222 0.91310 0.93540 0.06800 0.04060 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3322 3322 0 0 X 11026818 915699 144594 1060293 9966525 0 9966525 8976252 144594 144594 8831658 0 8831658 PART X, LINE 2: THE ORGANIZATION IS QUALIFIED AS A TAX EXEMPT ORGANIZATION UNDER EXISTING PROVISIONS OF THE INTERNAL REVENUE CODE SECTION 501(C)(3) AND, THEREFORE, HAS MADE NO PROVISION FOR FEDERAL OR STATE INCOME TAXES IN THE ACCOMPANYING FINANCIAL STATEMENTS. THE ORGANIZATION IS ANNUALLY REQUIRED TO FILE A FORM 990 RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX WITH THE INTERNAL REVENUE SERVICE AND HAS NOT FILED FORM 990-T, UNRELATED BUSINESS INCOME TAX. THE ORGANIZATION IS NO LONGER SUBJECT TO U.S. FEDERAL OR STATE INCOME TAX EXAMINATIONS BY TAX AUTHORITIES FOR YEARS BEFORE 2019. THE ORGANIZATION DOES NOT ANTICIPATE SIGNIFICANT CHANGES IN ITS TAX POSITIONS OVER THE NEXT 12 MONTHS. PART XI, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 144,594. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 144,594. SUB-SAHARAN AFRICA 0 22 PROGRAM SERVICES SEE PART V FOR DESCRIPTION 2506195 0 22 0 22 0 44 2506195 0 2506195 0 0 0 0 0 0 PART I, LINE 2: THE ORGANIZATION USES AN ACCOUNTING SYSTEM THAT IDENTIFIES GRANT EXPENSES BY PROJECT AND COST CATEGORY. GRANT EXPENSES MUST FOLLOW THE ORGANIZATION APPROVAL PROCESS, BUDGETS ARE APPROVED BY THE FUNDING AGENCY AND BUDGET VERSUS ACTUAL REPORTS ARE MONITORED ON A REGULAR BASIS. PART III ACCOUNTING METHOD: SCHEDULE F, PART I, LINE 3, COLUMN (E) SPECIFIC TYPES OF SERVICES IN REGION: THROUGH ITS GLOBAL HEALTH PARTNERSHIPS (GHP) PROGRAM, CLSI IS DEDICATED TO BUILDING INDIGENOUS LABORATORY CAPACITY AND IMPLEMENTING QUALITY IMPROVEMENTS IN RESOURCE-CONSTRAINED COUNTRIES THROUGH ASSESSMENTS, TRAINING, AND MENTORSHIPS BASED ON CRITICAL NEEDS AND LABORATORY BEST PRACTICES. ADDITIONALLY, CLSI SUPPORTS BROADER COUNTRY GOALS OF NHANCING THE ENTIRE NATIONAL LABORATORY SYSTEM, WHICH PLAYS A PIVOTAL ROLE IN THE FOUNDATION FOR A COUNTRY'S HEALTH CARE NETWORK. LABORATORY DATA ARE ESSENTIAL FOR CLINICIANS TO ACCURATELY ASSESS THE STATUS OF PATIENTS' HEALTH, MAKE ACCURATE DIAGNOSES, FORMULATE TREATMENT PLANS, AND SUBSEQUENTLY MONITOR THE EFFECTS OF TREATMENT. THE CLINICIAN MUST HAVE CONFIDENCE IN THE ACCURACY OF THE TEST RESULTS FROM THE LABORATORY TO USE THEM FRO CLINICAL DIAGNOSIS AND TREATMENT. SINCE 2005, THE U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) HAS BEEN FUNDING LABORATORY CAPACITY BUILDING PROGRAMS IN RECOGNITION OF THE VITAL ROLE OF LABORATORIES IN COMBATING THE AIDS EPIDEMIC. CLSI HAS WORKED IN AFRICA, CENTRAL AND SOUTHEAST ASIA, AND EASTERN EUROPE FOR OVER FIFTEEN YEARS WITH FUNDING FROM PEPFAR TO HELP RESOURCE-CONSTRAINED COUNTRIES IMPROVE THE QUALITY OF THEIR LABORATORY NETWORKS, AND THE EFFICIENCY AND ACCURACY OF THEIR LABORATORY RESULTS. PEPFAR'S INVESTMENT IN IMPROVING LABORATORY CAPACITY HAS PAID OFF SIGNIFICANTLY. MORE PATIENTS ACCURATELY DIAGNOSED AS HIV-POSITIVE HAVE RESULTED IN MORE PEOPLE RECEIVING THE TREATMENT THEY NEED. THIS NOT ONLY HELPS THE PATIENTS LIVE LONGER, HEALTHIER LIVES, BUT ALSO CAN PROTECT THEIR HIV-NEGATIVE PARTNERS FROM CONTRACTING THE DISEASE. IN ADDITION, CORRECTLY DIAGNOSING A PREGNANT WOMAN AND STARTING HER ON ANTIRETROVIRAL TREATMENT CAN PREVENT HER CHILDREN FROM BEING BORN HIV-POSITIVE. IMPROVED LABORATORY SYSTEMS ALSO INCREASE ACCESS TO RELIABLE, QUALITY DIAGNOSTIC SERVICES FOR TUBERCULOSIS AND OTHER OPPORTUNISTIC INFECTIONS. FOR OVER FIFTEEN YEARS, CLSI'S GHP STAFF, CONTRACTORS AND VOLUNTEERS HAVE PROVIDED HUNDREDS OF WORKSHOPS IN 20 DIFFERENT COUNTRIES REACHING THOUSANDS OF LABORATORY PROFESSIONALS. THESE WORKSHOPS HAVE COVERED A BROAD RANGE OF TOPICS, INCLUDING QUALITY MANAGEMENT SYSTEMS, STRATEGIC PLANNING, QUALITY CONTROL AND QUALITY ASSURANCES, VERIFICATION AND VALIDATION, AND LABORATORY ASSESSOR AND MENTOR TRAINING. CLSI MENTORS HAVE PROVIDED OVER 5,000 HOURS OF SIDE BY SIDE MENTORING IN AFRICAN AND CENTRAL ASIAN LABORATORIES, ASSISTING OVER 60 LABORATORIES IN THEIR BID FOR ACCREDITATION TO INTERNATIONALLY RECOGNIZED STANDARDS. CLSI HAS COLLABORATED ON PROJECTS WITH A RANGE OF NONPROFIT PARTNERS. X X X X 1 0 0 0 0 1 0 0 0 GLEN FINE FORMER CEO AND BOARD MEMBE 238289 0 127617 0 0 0 0 0 20346 0 386252 0 0 0 BARBARA J JONES CEO AND BOARD MEMBER 237221 0 0 0 0 0 0 0 12476 0 249697 0 0 0 PATRICK MATETA VP GLOBAL HEALTH PARTNERSH 181584 0 34967 0 0 0 0 0 31800 0 248351 0 0 0 PATRICK MCGINN FORMER VP MARKETING & MEMBERSHIP 191418 0 37344 0 0 0 0 0 17858 0 246620 0 0 0 JENNIFER ADAMS VP STANDARDS & QUALITY 188775 0 32454 0 0 0 0 0 21614 0 242843 0 0 0 CECILIA PORTO VP, FINANCE AND ACCOUNTING 158238 0 28001 0 0 0 0 0 23113 0 209352 0 0 0 DAVID STERRY DIRECTOR, STANDARDS DEVELO 115337 0 11307 0 0 0 0 0 26156 0 152800 0 0 0 PART I, LINE 4A PATRICK MCGINN, VICE PRESIDENT OF MARKETING, WAS TERMINATED ON SEPTEMEBER 1, 2022. A SEVERANCE OF $48,080 WAS PAID UPON EXECUTION OF THE SEVERANCE AGREEMENT. PART I, LINE 6 CLSI'S BONUS POLICY STATES THAT THE PAYMENT CALCULATION IS TO BE BASED ON ORGANIZATION, TEAM, AND INDIVIDUAL GOALS. ONE OF THE ORGANIZATION'S GOALS IS TO MEET BUDGET. FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: THE MISSION OF CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI) IS TO "DEVELOP CLINICAL AND LABORATORY PRACTICES AND PROMOTE THEIR USE WORLDWIDE." WORKING TOGETHER, CLSI STAFF AND VOLUNTEER EXPERTS GUIDE THE DEVELOPMENT AND PROMOTE THE USE OF VOLUNTARY LABORATORY STANDARDS AND GUIDELINES WITHIN THE US AND INTERNATIONAL HEALTH CARE COMMUNITIES. CLSI FACILITATES A UNIQUE PROCESS OF DEVELOPING THESE TESTING STANDARDS BASED ON INPUT FROM AND CONSENSUS AMONG INDUSTRY, GOVERNMENT, AND HEALTH CARE PROFESSIONALS. IMPROVING THE QUALITY OF PATIENT CARE BY FOSTERING EXCELLENCE IN LABORATORY MEDICINE IS THE DRIVING FORCE BEHIND THE CREATION OF EVERY CLSI PRODUCT AND PROGRAM. FOUNDED IN 1968 AS A FOR-PROFIT STANDARDS DEVELOPMENT MEMBERSHIP ORGANIZATION, CLSI HAS EARNED THE CONFIDENCE AND RECOGNITION OF GOVERNMENT REGULATORY BODIES SUCH AS THE US FOOD AND DRUG ADMINISTRATION, CENTERS FOR DISEASE CONTROL AND PREVENTION, AND ORGANIZATIONS SUCH AS THE CENTERS FOR MEDICARE AND MEDICAID SERVICES THAT EITHER DIRECTLY ACCREDIT OR AUTHORIZE DEEMED STATUS ACCREDITATION STATUS. CLSI, ON BEHALF OF THE AMERICAN NATIONAL STANDARDS INSTITUTE, HAS SERVED FOR OVER 25 YEARS AS THE SECRETARIAT FOR THE INTERNATIONAL ORGANIZATION FOR STANDARDIZATION TECHNICAL COMMITTEE (TC 212) THAT AUTHORS GLOBAL STANDARDS FOR THE MEDICAL LABORATORY. CLSI IS FUNDED BY MEMBERSHIP DUES, THE SALES OF ITS PRODUCTS AND SERVICES, SPONSORSHIPS, AND GRANTS. CLSI STAFF, CONTRACTORS AND VOLUNTEERS PROVIDE SERVICES AND HANDS-ON SUPPORT TO LABORATORIES IN RESOURCE CONSTRAINED COUNTRIES, HELPING THEM ACHIEVE SUSTAINABLE QUALITY WITH SYSTEMS TO BETTER DIAGNOSE AND TREAT PATIENTS WITH INFECTIOUS DISEASES. THROUGH PARTNERSHIPS WITH THE US GOVERNMENT, UNIVERSITIES, AND OTHER NONPROFIT ORGANIZATIONS, CLSI HAS WORKED IN MORE THAN 20 COUNTRIES IN AFRICA, CENTRAL ASIA, SOUTH AMERICA, AND EASTERN EUROPE. FOR OVER 50 YEARS, OUR MEMBERS, VOLUNTEERS, AND CUSTOMERS HAVE MADE CLSI A RESPECTED, TRANSFORMATIVE LEADER IN THE DEVELOPMENT AND IMPLEMENTATION OF CLINICAL AND LABORATORY TESTING STANDARDS. THROUGH OUR UNIFIED EFFORTS, WE WILL CONTINUE TO SET AND UPHOLD THE STANDARDS THAT DRIVE QUALITY TEST RESULTS, ENHANCE PATIENTCARE DELIVERY, AND IMPROVE THE PUBLIC'S HEALTH AROUND THE WORLD. FORM 990, PART III, LINE 4A, PROGRAM SERVICE DESCRIPTION: THE DEVELOPMENT OF THE ORGANIZATION'S INTERNATIONAL OUTREACH INSTITUTE 23-7089361 CLINICAL AND LABORATORY STANDARDS INITIATIVE, THE GLOBAL HEALTH PARTNERSHIPS PROGRAM: CLSI STAFF AND VOLUNTEERS PROVIDE TRAINING AND EDUCATION SERVICES AND HANDS-ON SUPPORT OF LABORATORIES IN RESOURCE-CONSTRAINED COUNTRIES, HELPING THEM ACHIEVE SUSTAINABLE QUALITY WITH SYSTEMS TO BETTER DIAGNOSE AND TREAT PATIENTS WITH INFECTIOUS DISEASES. THROUGH PARTNERSHIPS WITH THE US GOVERNMENT, UNIVERSITIES, AND OTHER NONPROFIT ORGANIZATIONS, CLSI HAS WORKED IN MORE THAN 20 COUNTRIES IN AFRICA, CENTRAL ASIA, CENTRAL AMERICA AND EASTERN EUROPE FOR OVER 50 YEARS, OUR MEMBERS, VOLUNTEERS AND CUSTOMERS HAVE MADE CLSI A RESPECTED, TRANSFORMATIVE LEADER IN THE DEVELOPMENT AND IMPLEMENTATION OF CLINICAL AND LABORATORY TESTING STANDARDS. THROUGH OUR UNIFIED EFFORTS, WE WILL CONTINUE TO SET AND UPHOLD THE STANDARDS THAT DRIVE QUALITY TEST RESULTS, ENHANCE PATIENT CARE DELIVERY, AND IMPROVE THE PUBLIC'S HEALTH AROUND THE WORLD. FORM 990, PART VI, SECTION A, LINE 1A CLSI'S EXECUTIVE COMMITTEE IS COMPRISED OF THE OFFICERS OF THE BOARD OF DIRECTORS. THEY MEET ON A MONTHLY BASIS AND CAN MAKE DECISIONS ON BEHALF OF THE BOARD UNLESS WHERE IT IS EXPLICITLY NOTED THAT THE FULL BOARD MUST APPROVE/VOTE PER OUR BY-LAWS. FORM 990, PART VI, SECTION A, LINE 6 ALL ORGANIZATIONS PAYING MEMBERSHIP DUES ARE CONSIDERED MEMBERS OF CLSI FORM 990, PART VI, SECTION A, LINE 7A POWER TO ELECT OR APPOINT ONE OR MORE MEMBERS OF THE GOVERNING BODY FORM 990, PART VI, SECTION B, LINE 11B INDEPENDENT AUDITORS PREPARE THE ANNUAL FORM 990 AND THE FORM IS SENT TO THE BOARD OF DIRECTORS FOR REVIEW PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS AND MEMBERS OF THE BOARD ARE REQUIRED TO COMPLETE A DISCLOSURE OF INTEREST FORM AND IT IS A STANDING AGENDA ITEM AT ALL BOARD MEETINGS FOR UPDATES TO EACH MEMBER'S. FORM 990, PART VI, SECTION B, LINE 15 INDUSTRY COMPARABILITY DATA AND OTHER ANALYSIS IS USED TO DETERMINE APPROPRIATE COMPENSATION FOR THE CEO AS WELL AS OTHER OFFICERS AND KEY EMPLOYEES. THE CEO'S SALARY IS APPROVED BY THE PRESIDENT OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 ALL GOVERNING DOCUMENTS, POLICIES AND PROCEDURES, FINANCIAL STATEMENTS AND COPIES OF FORM 990 ARE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 921,584. MANAGEMENT AND GENERAL EXPENSES 141,935. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,063,519. FORM 990, PART XII, LINE 2C CLSI HAS A FINANCE COMMITTEE WHICH TAKES RESPONSIBLITY FOR OVERSIGHT OF THE ANNUAL FINANCIAL STATEMENT AUDIT. THERE WERE NO CHANGES TO THIS PROCESS FROM PRIOR YEARS.